X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (30) 30
female (27) 27
male (27) 27
middle aged (25) 25
cardiac & cardiovascular systems (23) 23
mortality (21) 21
aged (20) 20
heart failure (18) 18
treatment outcome (17) 17
prognosis (11) 11
heart attack (10) 10
index medicus (10) 10
myocardial infarction - drug therapy (10) 10
risk factors (10) 10
adult (9) 9
heart failure - drug therapy (9) 9
double-blind method (8) 8
drug therapy (8) 8
heart failure - mortality (8) 8
angioplasty (7) 7
cardiotonic agents - therapeutic use (7) 7
follow-up studies (7) 7
heart attacks (7) 7
therapy (7) 7
valsartan (7) 7
captopril - therapeutic use (6) 6
clinical trials (6) 6
myocardial infarction (6) 6
prevalence (6) 6
proportional hazards models (6) 6
prospective studies (6) 6
tetrazoles - therapeutic use (6) 6
valine - analogs & derivatives (6) 6
valine - therapeutic use (6) 6
abridged index medicus (5) 5
angiotensin-converting enzyme inhibitors - therapeutic use (5) 5
cardiac patients (5) 5
cardiovascular (5) 5
coronary angiography (5) 5
drug therapy, combination (5) 5
hospitalization (5) 5
milrinone - therapeutic use (5) 5
multicenter studies as topic (5) 5
myocardial infarction - complications (5) 5
myocardial infarction - mortality (5) 5
outcomes (5) 5
peripheral vascular disease (5) 5
randomized controlled trials as topic (5) 5
randomized trial (5) 5
survival (5) 5
survival analysis (5) 5
survival rate (5) 5
thrombolytic therapy (5) 5
tissue plasminogen-activator (5) 5
trial (5) 5
usage (5) 5
adolescent (4) 4
cardiology (4) 4
health aspects (4) 4
heart-failure (4) 4
hospital mortality (4) 4
intravenous milrinone (4) 4
length of stay (4) 4
medicine, general & internal (4) 4
patients (4) 4
prognostic-significance (4) 4
retrospective studies (4) 4
time factors (4) 4
ventricular dysfunction, left - drug therapy (4) 4
acute disease (3) 3
adhd (3) 3
adolescents (3) 3
calcium sensitizer (3) 3
captopril (3) 3
care and treatment (3) 3
clinical outcomes (3) 3
cohort studies (3) 3
combined modality therapy (3) 3
complications (3) 3
coronary artery bypass (3) 3
disease (3) 3
electrocardiography (3) 3
heart (3) 3
heart failure - complications (3) 3
heart failure - epidemiology (3) 3
heart failure - etiology (3) 3
infusion (3) 3
medical research (3) 3
milrinone - administration & dosage (3) 3
multivariate analysis (3) 3
patient outcomes (3) 3
predictive value of tests (3) 3
prevention (3) 3
quality of life (3) 3
risk (3) 3
risk assessment (3) 3
studies (3) 3
surgery (3) 3
thrombolysis (3) 3
trends (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 2003, Volume 349, Issue 20, pp. 1893 - 1906
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2017, Volume 376, Issue 21, pp. 2032 - 2042
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2004, Volume 351, Issue 13, pp. 1285 - 1295
Journal Article
Journal of the American Academy of Child & Adolescent Psychiatry, ISSN 0890-8567, 2011, Volume 50, Issue 9, pp. 903 - 914
Objective To evaluate the efficacy and safety of osmotic-release methylphenidate (OROS-MPH) compared with placebo for attention-deficit/hyperactivity disorder... 
Pediatrics | Psychiatry | osmotic-release methylphenidate | ADHD | substance use disorders | randomized controlled trial | Substance use disorders | Osmotic-release methylphenidate | Randomized controlled trial | YOUNG-ADULTS | PLACEBO | PSYCHIATRY | PSYCHOLOGY, DEVELOPMENTAL | RELIABILITY | PREVALENCE | ADULT ADHD | DESIGNS | SAMPLE | ABUSE | PEDIATRICS | ATOMOXETINE | VALIDITY | Parent Attitudes | Therapy | Behavior Modification | Cognitive Restructuring | Drug Therapy | Scores | Substance Abuse | Outcomes of Treatment | Comparative Analysis | Attention Deficit Hyperactivity Disorder | Adolescents | Rating Scales | Symptoms (Individual Disorders) | Methylphenidate - administration & dosage | Humans | Male | Treatment Outcome | Combined Modality Therapy | Methylphenidate - adverse effects | Substance-Related Disorders - therapy | Attention Deficit Disorder with Hyperactivity - drug therapy | Central Nervous System Stimulants - therapeutic use | Central Nervous System Stimulants - adverse effects | Adolescent | Methylphenidate - therapeutic use | Delayed-Action Preparations - therapeutic use | Placebos | Cognitive Therapy | Female | Attention Deficit Disorder with Hyperactivity - diagnosis | Central Nervous System Stimulants - administration & dosage | Substance-Related Disorders - diagnosis | Psychotropic drugs | Clinical trials | Drug abuse | Cognitive therapy | Child psychology
Journal Article
Journal Article
Journal of Clinical Psychiatry, ISSN 0160-6689, 12/2010, Volume 71, Issue 12, pp. 1680 - 1688
Journal Article
Journal Article
Circulation, ISSN 0009-7322, 09/2004, Volume 110, Issue 12, pp. 1572 - 1578
... ( use of diabetic therapy or diabetes diagnosed at randomization [ median 4.9 d after infarction... 
Heart failure | Myocardial infarction | Prognosis | Diabetes mellitus | MORTALITY | heart failure | CARDIAC & CARDIOVASCULAR SYSTEMS | myocardial infarction | BLOOD-GLUCOSE | RISK | diabetes mellitus | PREVALENCE | prognosis | FASTING GLUCOSE | COOPERATIVE CARDIOVASCULAR PROJECT | HYPERGLYCEMIA | LEFT-VENTRICULAR DYSFUNCTION | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | THROMBOLYTIC ERA | CORONARY-ARTERY-DISEASE | Myocardial Infarction - epidemiology | Follow-Up Studies | Valsartan | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Humans | Middle Aged | Ventricular Dysfunction, Left - complications | Male | Risk | Life Tables | Valine - administration & dosage | Captopril - therapeutic use | Myocardial Infarction - therapy | Multicenter Studies as Topic | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Time Factors | Tetrazoles - administration & dosage | Female | Stroke - epidemiology | Diabetes Mellitus - diagnosis | Drug Therapy, Combination | Heart Failure - epidemiology | Angiotensin II Type 1 Receptor Blockers - administration & dosage | Heart Failure - complications | Ventricular Dysfunction, Left - epidemiology | Randomized Controlled Trials as Topic - statistics & numerical data | Comorbidity | Valine - analogs & derivatives | Medical Records | Proportional Hazards Models | Treatment Outcome | Angiotensin-Converting Enzyme Inhibitors - administration & dosage | Diabetes Complications - mortality | Heart Failure - drug therapy | Myocardial Infarction - complications | Captopril - administration & dosage | Ventricular Dysfunction, Left - drug therapy | Diabetes Mellitus - epidemiology | Tetrazoles - therapeutic use | Valine - therapeutic use | Aged | Cohort Studies
Journal Article
Journal Article
European Journal of Heart Failure, ISSN 1388-9842, 2006, Volume 8, Issue 6, pp. 591 - 598
Abstract Aims To characterize the relationship between known and newly diagnosed atrial fibrillation (AF) and the risk of death and major cardiovascular (CV)... 
prognosis | atrial fibrillation | acute myocardial infarction | Acute myocardial infarction | Atrial fibrillation | Prognosis | TRIAL | CARDIAC & CARDIOVASCULAR SYSTEMS | RHYTHM CONTROL | EXPERIENCE | PROGNOSTIC-SIGNIFICANCE | VALIANT | VALSARTAN | Myocardial Infarction - mortality | Outcome Assessment (Health Care) | Valsartan | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Humans | Middle Aged | Ventricular Dysfunction, Left - complications | Male | Captopril - therapeutic use | Time Factors | Atrial Fibrillation - mortality | Female | Atrial Fibrillation - diagnosis | Acute Disease | Risk Assessment | Risk Factors | Valine - analogs & derivatives | Atrial Fibrillation - complications | Proportional Hazards Models | Cardiac Output, Low - complications | Myocardial Infarction - complications | Myocardial Infarction - drug therapy | Survival Analysis | Tetrazoles - therapeutic use | Valine - therapeutic use | Aged | Heart failure | Universities and colleges | Cardiac patients | Heart attack | Atrial Fibrillation/complications/diagnosis/mortality | Ventricular Dysfunction | Cardiac Output | Angiotensin II Type 1 Receptor Blockers/therapeutic use | Tetrazoles/therapeutic use | Kardiologi | Valine/analogs & derivatives/therapeutic use | Left/complications | Captopril/therapeutic use | Low/complications | Cardiac and Cardiovascular Systems | Myocardial Infarction/complications/drug therapy/mortality
Journal Article